Neuromelanin-sensitive MRI as a biomarker for individualized deep brain stimulation in Parkinson's disease: Associations between substantia nigra imaging and therapeutic outcomes
{"title":"Neuromelanin-sensitive MRI as a biomarker for individualized deep brain stimulation in Parkinson's disease: Associations between substantia nigra imaging and therapeutic outcomes","authors":"Yinling Zhou , Yindi Zhang , Guo Li , Wei Zhang","doi":"10.1016/j.parkreldis.2026.108205","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Deep brain stimulation (DBS) of the subthalamic nucleus (STN) effectively treats advanced Parkinson's disease (PD), yet motor and non-motor outcomes vary considerably. Neuromelanin-sensitive MRI (NM-MRI) visualizes dopaminergic neuron loss in the substantia nigra pars compacta (SNc) and may serve as a predictive biomarker.</div></div><div><h3>Objectives</h3><div>To explore quantitative associations between preoperative NM-MRI SNc characteristics and postoperative clinical improvement in PD patients undergoing STN-DBS.</div></div><div><h3>Methods</h3><div>In this prospective cohort study, 33 PD patients scheduled for bilateral STN-DBS and 16 age-matched healthy controls were enrolled. Clinical outcomes at 3 months post-surgery included percentage improvement in Unified PD Rating Scale Part III (UPDRS-III), PD Questionnaire-39 (PDQ-39), and levodopa equivalent daily dose (LEDD). High-resolution T1-weighted and NM-sensitive sequences were acquired at 3.0 T; SNc volume and signal-to-noise ratio (SNR) were calculated after manual region-of-interest delineation.</div></div><div><h3>Results</h3><div>Contralesional SNc volume and SNR were significantly reduced versus ipsilesional sides (both P < 0.001) and controls (P = 0.043 and P = 0.031). Contralesional SNc volume correlated moderately with UPDRS-III improvement (r = 0.508, P = 0.003), whereas SNR correlated strongly with PDQ-39 improvement (r = 0.599, P < 0.001). Multivariable regression confirmed contralesional volume as an independent predictor of motor response and SNR of quality-of-life response. ROC analysis yielded AUCs of 0.785 for volume predicting good motor outcome and 0.724 for SNR predicting good quality-of-life outcome, increasing to 0.800 and 0.786 when combined with Hoehn-Yahr stage.</div></div><div><h3>Conclusion</h3><div>Preoperative NM-MRI-derived SNc volume and SNR are robust, non-invasive biomarkers for predicting motor and quality-of-life responses to STN-DBS, supporting personalized patient selection and precision neuromodulation in Parkinson's disease. Larger longitudinal studies are warranted.</div></div>","PeriodicalId":19970,"journal":{"name":"Parkinsonism & related disorders","volume":"144 ","pages":"Article 108205"},"PeriodicalIF":4.3000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Parkinsonism & related disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1353802026000313","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/28 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) effectively treats advanced Parkinson's disease (PD), yet motor and non-motor outcomes vary considerably. Neuromelanin-sensitive MRI (NM-MRI) visualizes dopaminergic neuron loss in the substantia nigra pars compacta (SNc) and may serve as a predictive biomarker.
Objectives
To explore quantitative associations between preoperative NM-MRI SNc characteristics and postoperative clinical improvement in PD patients undergoing STN-DBS.
Methods
In this prospective cohort study, 33 PD patients scheduled for bilateral STN-DBS and 16 age-matched healthy controls were enrolled. Clinical outcomes at 3 months post-surgery included percentage improvement in Unified PD Rating Scale Part III (UPDRS-III), PD Questionnaire-39 (PDQ-39), and levodopa equivalent daily dose (LEDD). High-resolution T1-weighted and NM-sensitive sequences were acquired at 3.0 T; SNc volume and signal-to-noise ratio (SNR) were calculated after manual region-of-interest delineation.
Results
Contralesional SNc volume and SNR were significantly reduced versus ipsilesional sides (both P < 0.001) and controls (P = 0.043 and P = 0.031). Contralesional SNc volume correlated moderately with UPDRS-III improvement (r = 0.508, P = 0.003), whereas SNR correlated strongly with PDQ-39 improvement (r = 0.599, P < 0.001). Multivariable regression confirmed contralesional volume as an independent predictor of motor response and SNR of quality-of-life response. ROC analysis yielded AUCs of 0.785 for volume predicting good motor outcome and 0.724 for SNR predicting good quality-of-life outcome, increasing to 0.800 and 0.786 when combined with Hoehn-Yahr stage.
Conclusion
Preoperative NM-MRI-derived SNc volume and SNR are robust, non-invasive biomarkers for predicting motor and quality-of-life responses to STN-DBS, supporting personalized patient selection and precision neuromodulation in Parkinson's disease. Larger longitudinal studies are warranted.
期刊介绍:
Parkinsonism & Related Disorders publishes the results of basic and clinical research contributing to the understanding, diagnosis and treatment of all neurodegenerative syndromes in which Parkinsonism, Essential Tremor or related movement disorders may be a feature. Regular features will include: Review Articles, Point of View articles, Full-length Articles, Short Communications, Case Reports and Letter to the Editor.